LIVER_CANCER

作品数：694被引量：3140H指数：25
导出分析报告
相关作者：顾宁颜士岩王子妤路新丽张东生更多>>
相关机构：同济大学第二军医大学厦门大学华西医科大学更多>>
相关期刊：更多>>
相关基金：国家自然科学基金国家重点基础研究发展计划广东省自然科学基金中国博士后科学基金更多>>
-
在结果中检索

检索结果分析

结果分析中...
选择条件：
  • 期刊=Hepatobiliary Surgery and Nutritionx
共 条 记 录，以下是1-10
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Selective internal radiation therapy across Barcelona Clinic Liver Cancer(BCLC)stages of hepatocellular carcinoma:literature review
《Hepatobiliary Surgery and Nutrition》2024年第6期974-990,共17页Paul Vigneron Maria Stella Franzè Julia Chalaye Vania Tacher Anna Sessa Alain Luciani Hicham Kobeiter Hélène Regnault Ancuta Bejan Julien Calderaro Rami Rhaiem Daniele Sommacale Giovanni Raimondo Vincent Leroy Raffaele Brustia Giuliana Amaddeo 
Background and Objective:Selective internal radiation therapy(SIRT)represents an endovascular treatment option for patients with hepatocellular carcinoma(HCC).Its use is widely recognized in the intermediate and advan...
关键词：Hepatocellular carcinoma(HCC) RADIOEMBOLIZATION yttrium-90(90Y) selective internal radiation therapy(SIRT) transarterial radioembolization(TARE) 
Cross-continental insights into liver cancer: an East vs. West epidemiology
《Hepatobiliary Surgery and Nutrition》2024年第4期739-741,共3页Mohamad Azhar Meerun Boris Guiu 
Liver cancer,encompassing both primary and secondary forms,presents a formidable global health challenge.According to the GLOBOCAN 2020 database,liver cancer ranks as the sixth most common cancer globally in terms of ...
关键词：Hepatocellular carcinoma(HCC) intrahepatic cholangiocarcinoma(ICC) EPIDEMIOLOGY 
Living donor liver transplantation can be a rescue treatment for hepatocellular carcinoma
《Hepatobiliary Surgery and Nutrition》2024年第4期742-744,共3页Jongman Kim 
Basic Research Program through the National Research Foundation of Korea(NRF)funded by the Ministry of Science and ICT(No.NRF-2023R1A2C2005946).Korean NRF did not influence the drafting of the manuscript.
For intermediate-stage hepatocellular carcinoma(HCC)in the Barcelona Clinic Liver Cancer(BCLC),transarterial chemoembolization(TACE)is advised as the initial treatment.The term“BCLC intermediate-stage HCC”(BCLC stag...
关键词：Living liver donors outcomes guidelines Barcelona Clinic Liver Cancer staging(BCLC staging) 
Time to say goodbye: from Barcelona to Milan and the modern management of hepatocellular carcinoma
《Hepatobiliary Surgery and Nutrition》2024年第3期548-550,共3页Georgia Sofia Karachaliou Nikolaos Dimitrokallis Dimitrios Moris 
Hepatocellular carcinoma(HCC)is the most common primary liver malignancy and one of the most common causes of cancer-related death with the projection to increase during the next few decades(1).During the last 3 decad...
关键词：Hepatocellular carcinoma(HCC) Barcelona Clinic Liver Cancer(BCLC) tumor burden score 
Global similarities: comparison of the Korean Liver Cancer Association chemoembolization guidelines for hepatocellular carcinoma to the National Comprehensive Cancer Network, American Association for the Study of Liver Diseases and Barcelona Clinic Liver Cancer recommendations
《Hepatobiliary Surgery and Nutrition》2024年第2期343-346,共4页Meaghan S.Dendy Case Daniel B.Brown 
Hepatocellular carcinoma(HCC)remains the third most common cause of cancer-related deaths worldwide(1).Transarterial chemoembolization(TACE)has been established as a therapeutic option in those patients who are outsid...
关键词：Hepatocellular carcinoma(HCC) therapeutic chemoembolization interventional radiology 
Primary sclerosing cholangitis and cholangiocarcinoma:the 2023 practice guidance and future perspectives
《Hepatobiliary Surgery and Nutrition》2024年第1期172-175,共4页Francesca Saffioti Vasileios K.Mavroeidis 
The 2023 practice guidance on primary sclerosing cholangitis(PSC)and cholangiocarcinoma(CCA)of the American Association for the Study of Liver Diseases(AASLD)came as a needful update to the previous 2010 guidelines on...
关键词：American Association for the Study of Liver Diseases(AASLD) GUIDELINES primary sclerosing cholangitis(PSC) liver cancer biliary cancer 
Primary liver cancer spectrum:current knowledge and the next steps
《Hepatobiliary Surgery and Nutrition》2024年第1期157-160,共4页Mohammad Saeid Rezaee-Zavareh Ekaterina K.Koltsova Yujin Hoshida Ju Dong Yang 
Hepatocellular carcinoma(HCC)and intrahepatic cholangiocarcinoma(iCCA)constitute the main subtypes of primary liver cancers(PLCs)as a major cause of cancer-related mortality and incidence.They emerge from varying quan...
关键词：Liver cancer spectrum hepatocellular carcinoma(HCC) cholangiocarcinoma(CCA) integrated analysis 
The power of prevention:how tenofovir and entecavir are changing the game in hepatocellular carcinoma被引量：1
《Hepatobiliary Surgery and Nutrition》2023年第6期936-940,共5页Endrit Shahini Rossella Donghia Antonio Facciorusso 
Introduction Individual patient data(IPD)meta-analysis by Choi et al.(1)compared hepatocellular carcinoma(HCC)risk between the entecavir(ETV)and tenofovir(TDF)in treatment-naïve chronic hepatitis B(CHB)patients using ...
关键词：Hepatocellular carcinoma(HCC) liver cancer cirrhosis hepatitis B virus(HBV) 
Large,multifocal or portal vein-invading hepatocellular carcinoma(HCC)downstaged by Y90 using personalized dosimetry:safety,pathological results and outcomes after surgery被引量：2
《Hepatobiliary Surgery and Nutrition》2023年第3期351-365,I0012,I0013,共17页Mohamad Azhar Meerun Carole Allimant Benjamin Rivière Astrid Herrero Fabrizio Panaro Eric Assenat Christophe Cassinotto Denis Mariano-Goulart Boris Guiu 
Background:Transarterial radioembolization(TARE)has recently been recognized as a bridging/downstaging therapy to surgery for early hepatocellular carcinomas(HCCs)with high rates of complete pathological necrosis(CPN)...
关键词：Selective internal radiation therapy hepatocellular carcinoma(HCC) liver cancer RESECTION transplantation 
Perioperative management of patients with liver cancer complicated with sarcopenia被引量：2
《Hepatobiliary Surgery and Nutrition》2022年第6期906-908,共3页Jiali Xing Xueshuai Wan Xinting Sang Huayu Yang Shunda Du 
This work was supported by grants from CAMS Innovation Fund for Medical Sciences(CIFMS)2021-I2M-1-014.
Primary liver cancer is one of the most common digestive system malignancies worldwide,with hepatocellular carcinomas accounting for about 90% of cases.It has a concealed onset,rapid progression,high degree of maligna...
关键词：LIVER ARTERIAL TREATMENT 
全选清除导出
共2页<12>
检索报告 对象比较 聚类工具 使用帮助 返回顶部